Your browser doesn't support javascript.
loading
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
Charalampous, Charalampos; Goel, Utkarsh; Kapoor, Prashant; Binder, Moritz; Buadi, Francis K; Cook, Joselle; Dingli, David; Dispenzieri, Angela; Fonder, Amie L; Gertz, Morie A; Gonsalves, Wilson; Hayman, Suzanne R; Hobbs, Miriam A; Hwa, Yi L; Kourelis, Taxiarchis; Lacy, Martha Q; Leung, Nelson; Lin, Yi; Warsame, Rahma; Kyle, Robert A; Rajkumar, S Vincent; Kumar, Shaji K.
Afiliação
  • Charalampous C; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Goel U; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Cook J; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Dingli D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Fonder AL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Gonsalves W; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hayman SR; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hobbs MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hwa YL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kourelis T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Leung N; Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Lin Y; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Warsame R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kyle RA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu.
Blood Cancer J ; 13(1): 183, 2023 12 11.
Article em En | MEDLINE | ID: mdl-38072941
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias de Plasmócitos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias de Plasmócitos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos